Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Peter Gale

Showing results (221-230 of 373) with videos related to

Pageof 38
Sort By:
Leukemia|June 18, 2020
Risk factors for death in 1859 subjects with COVID-19Lei Chen, Jianming Yu, Wenjuan He, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2006
Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemiaAthanasios Anagnostopoulos, Parameswaran N Hari, Waleska S Pérez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysisKamar Godder, Mary Eapen, Joseph H Laver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2020
Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid LeukemiaHui Wei, Ying Wang, Robert Peter Gale, et al.
Blood Cancer Journal|August 18, 2020
Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centreHuijun Huang, Changlu Xu, Jie Gao, et al.
Blood Advances|May 31, 2018
Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabineAndrew C Harris, Jaap J Boelens, Kwang Woo Ahn, et al.
Clinical Transplantation|April 21, 2019
Determine safety of outpatient chemotherapy and autotransplants using refrigerated, non-frozen grafts in persons with multiple sclerosisRobert Peter Gale, Gisela Berenice Gómez-Cruz, Juan Carlos Olivares-Gazca, et al.
Oncotarget|November 6, 2015
Prognostic impact of Epstein-Barr virus (EBV)-DNA copy number at diagnosis in chronic lymphocytic leukemiaJin-Hua Liang, Rui Gao, Yi Xia, et al.
Blood|July 2, 2002
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapseStephanie J Lee, John P Klein, A John Barrett, et al.
Leukemia|October 7, 2021
HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusionsElspeth A Bruford, Cristina R Antonescu, Andrew J Carroll, et al.
Pageof 38

Showing results (221-230 of 373) with videos related to

Sort By:
Pageof 38
Leukemia|June 18, 2020
Risk factors for death in 1859 subjects with COVID-19Lei Chen, Jianming Yu, Wenjuan He, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 26, 2006
Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemiaAthanasios Anagnostopoulos, Parameswaran N Hari, Waleska S Pérez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysisKamar Godder, Mary Eapen, Joseph H Laver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 8, 2020
Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid LeukemiaHui Wei, Ying Wang, Robert Peter Gale, et al.
Blood Cancer Journal|August 18, 2020
Severe ineffective erythropoiesis discriminates prognosis in myelodysplastic syndromes: analysis based on 776 patients from a single centreHuijun Huang, Changlu Xu, Jie Gao, et al.
Blood Advances|May 31, 2018
Comparison of pediatric allogeneic transplant outcomes using myeloablative busulfan with cyclophosphamide or fludarabineAndrew C Harris, Jaap J Boelens, Kwang Woo Ahn, et al.
Clinical Transplantation|April 21, 2019
Determine safety of outpatient chemotherapy and autotransplants using refrigerated, non-frozen grafts in persons with multiple sclerosisRobert Peter Gale, Gisela Berenice Gómez-Cruz, Juan Carlos Olivares-Gazca, et al.
Oncotarget|November 6, 2015
Prognostic impact of Epstein-Barr virus (EBV)-DNA copy number at diagnosis in chronic lymphocytic leukemiaJin-Hua Liang, Rui Gao, Yi Xia, et al.
Blood|July 2, 2002
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapseStephanie J Lee, John P Klein, A John Barrett, et al.
Leukemia|October 7, 2021
HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusionsElspeth A Bruford, Cristina R Antonescu, Andrew J Carroll, et al.
Pageof 38